Presenting Author: Duong T. Tran, PhD – National Drug and Alcohol Research Centre
### @@@ Jacqueline M. Cohen, PhD (she/her/hers) – Norwegian Institute of Public Health ### 1360547###Co-Author###Senior researcher###Norwegian Institute of Public Health###Co-Author: Jacqueline M. Cohen, PhD (she/her/hers) – Norwegian Institute of Public Health
### she/her/hers @@@ Sarah Donald – University of Otago ### 1994093###Co-Author######University of Otago###Co-Author: Sarah Donald – University of Otago
### @@@ Annelies L. Robijn, PhD MSc BSc – National Drug and Alcohol Research Centre ### 1994097###Co-Author###Research Fellow###National Drug and Alcohol Research Centre###Co-Author: Annelies L. Robijn, PhD MSc BSc – National Drug and Alcohol Research Centre
### @@@ Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden. ### 1062759###Co-Author###Assistant Professor###Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.###Co-Author: Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.
### @@@ Kari Furu, MPH, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway. ### 1063219###Co-Author###Senior researcher###Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.###Co-Author: Kari Furu, MPH, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
### she/her/hers @@@ Lianne Parkin, MB ChB, PhD – University of Otago ### 1994096###Co-Author######University of Otago###Co-Author: Lianne Parkin, MB ChB, PhD – University of Otago
### @@@ Sallie-Anne Pearson, PhD – UNSW Sydney ### 1358403###Co-Author###Professor of Health Systems###UNSW Sydney###Co-Author: Sallie-Anne Pearson, PhD – UNSW Sydney
### @@@ Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden. ### 1358377###Co-Author###Associate professor###Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.###Co-Author: Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.
### @@@ Helga Zoega – Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia. ### 1358124###Co-Author###Associate professor/professor###Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.###Co-Author: Helga Zoega – Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.
### @@@ Nicholas Zwar – Bond University ### 1994098###Co-Author######Bond University###Co-Author: Nicholas Zwar – Bond University
### @@@ Alys Havard, PhD (she/her/hers) – National Drug and Alcohol Research Centre ### 1358233###Co-Author###Senior Research Fellow###National Drug and Alcohol Research Centre###Co-Author: Alys Havard, PhD (she/her/hers) – National Drug and Alcohol Research Centre
### she/her/hersPresenting Author: Geetika Kalloo, PhD (she/her/hers) – Carelon Research
### she/her/hers @@@ Maria Guzman – Carelon Research ### 2325523###Co-Author######Carelon Research###Co-Author: Maria Guzman – Carelon Research
### @@@ Christopher L. Crowe – Carelon Research ### 2325524###Co-Author######Carelon Research###Co-Author: Christopher L. Crowe – Carelon Research
### @@@ Stephan Lanes – Carelon Research ### 2325146###Co-Author######Carelon Research###Co-Author: Stephan Lanes – Carelon Research
### @@@ Bahar C. Coley – Carelon Research ### 2325309###Co-Author######Carelon Research###Co-Author: Bahar C. Coley – Carelon Research
### @@@ David Martin, MD, MPH – Moderna, Inc. ### 1360465###Co-Author###Vice President, Clinical Safety and Risk Management###Moderna, Inc.###Co-Author: David Martin, MD, MPH – Moderna, Inc.
### @@@ Lei Zhu – Moderna, Inc. ### 1993192###Co-Author######Moderna, Inc.###Co-Author: Lei Zhu – Moderna, Inc.
### @@@ Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc. ### 1655853###Co-Author###Director, Global Safety Epidemiologist###Moderna, Inc.###Co-Author: Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ Daina B. Esposito, MPH, PhD (she/her/hers) – Moderna, Inc. ### 1655290###Co-Author###Sr. Director, Global Safety Epidemiologist###Moderna, Inc.###Co-Author: Daina B. Esposito, MPH, PhD (she/her/hers) – Moderna, Inc.
### she/her/hersPresenting Author: Ashleigh Hooimeyer – The University of Sydney
### @@@ Eliza McEwin – The University of Sydney ### 1655937###Co-Author######The University of Sydney###Co-Author: Eliza McEwin – The University of Sydney
### @@@ Annim Mohammad – The University of Sydney ### 1655940###Co-Author###Research Associate###The University of Sydney###Co-Author: Annim Mohammad – The University of Sydney
### @@@ Zhicheng Wang, PhD – The University of Sydney ### 2325712###Co-Author######The University of Sydney###Co-Author: Zhicheng Wang, PhD – The University of Sydney
### @@@ Kellia Chiu, PhD – University of Toronto ### 2325717###Co-Author######University of Toronto###Co-Author: Kellia Chiu, PhD – University of Toronto
### @@@ Sally McDonald – The University of Sydney ### 2325718###Co-Author######The University of Sydney###Co-Author: Sally McDonald – The University of Sydney
### @@@ Barbara Mintzes, PhD (she/her/hers) – The University of Sydney ### 1360156###Co-Author###Professor of Evidence-based Pharmaceutical Policy###The University of Sydney###Co-Author: Barbara Mintzes, PhD (she/her/hers) – The University of Sydney
### she/her/hersCo-Author: Zaba Valtuille, MSc (she/her/hers) – Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France
### she/her/hers @@@ Eric Aquaviva, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325625###Co-Author######Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###Co-Author: Eric Aquaviva, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Vincent Trebossen, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325626###Co-Author######Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###Co-Author: Vincent Trebossen, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Naim Ouldali, MD, PhD – Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325628###Co-Author######Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###Co-Author: Naim Ouldali, MD, PhD – Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Aurelie Bourmaud, MD, PhD – Clinical Epidemiology Unit, INSERM CIC1426, Robert Debré University Hospital, APHP.Nord, Paris Cité University- Paris, France ### 2325629###Co-Author######Clinical Epidemiology Unit, INSERM CIC1426, Robert Debré University Hospital, APHP.Nord, Paris Cité University- Paris, France###Co-Author: Aurelie Bourmaud, MD, PhD – Clinical Epidemiology Unit, INSERM CIC1426, Robert Debré University Hospital, APHP.Nord, Paris Cité University- Paris, France
### @@@ Stephane Sclison – IQVIA – Consulting Services & Analytics Department ### 2325630###Co-Author######IQVIA – Consulting Services & Analytics Department###Co-Author: Stephane Sclison – IQVIA – Consulting Services & Analytics Department
### @@@ Alexandre Gomez – IQVIA – Consulting Services & Analytics Department ### 2325631###Co-Author######IQVIA – Consulting Services & Analytics Department###Co-Author: Alexandre Gomez – IQVIA – Consulting Services & Analytics Department
### @@@ Alexis Revet, MD, PhD – Department of Child and Adolescent Psychiatry, Toulouse University Hospital, Toulouse, France ### 2325632###Co-Author######Department of Child and Adolescent Psychiatry, Toulouse University Hospital, Toulouse, France###Co-Author: Alexis Revet, MD, PhD – Department of Child and Adolescent Psychiatry, Toulouse University Hospital, Toulouse, France
### @@@ Hugo Peyre, MD, PhD – Autism Reference Centre of Languedoc-Roussillon CRA-LR, Excellence Centre for Autism and Neurodevelopmental disorders CeAND, Montpellier University Hospital, MUSE University, France ### 2325633###Co-Author######Autism Reference Centre of Languedoc-Roussillon CRA-LR, Excellence Centre for Autism and Neurodevelopmental disorders CeAND, Montpellier University Hospital, MUSE University, France###Co-Author: Hugo Peyre, MD, PhD – Autism Reference Centre of Languedoc-Roussillon CRA-LR, Excellence Centre for Autism and Neurodevelopmental disorders CeAND, Montpellier University Hospital, MUSE University, France
### @@@ Richard Delorme, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325634###Co-Author######Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###Co-Author: Richard Delorme, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Florentia Kaguelidou, MD, PhD – Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France ### 1093556###Presenting Author######Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France###Presenting Author: Florentia Kaguelidou, MD, PhD – Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France
###Moderator: Greta A. Bushnell, PhD, MSPH – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA
### @@@ Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy ### 1358158###Moderator###Lecturer/Assistant Professor###UCL School of Pharmacy###Moderator: Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy
### he/him/hisLead Speaker: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Robert Ball, MD, MPH, ScM – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration ### 1359919###Speaker###Deputy Super Office Director###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration###Speaker: Robert Ball, MD, MPH, ScM – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration
### @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Speaker###Head of Real-World Evidence###European Medicines Agency###Speaker: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1046819###Speaker###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###Speaker: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his @@@ Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol ### 1358413###Speaker###Assistant Professor###Erasmus MC and IDIAPJGol###Speaker: Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol
### @@@ Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Speaker###Professor of Pharmaco-and Device Epidemiology###University of Oxford###Speaker: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/hisLead Speaker: Kaley N. Hayes, PharmD, PhD – Brown University
### @@@ Joshua David Niznik, PharmD, PhD (he/him/his) – University of North Carolina ### 1655386###Speaker###Assistant Professor###University of North Carolina###Speaker: Joshua David Niznik, PharmD, PhD (he/him/his) – University of North Carolina
### he/him/his @@@ Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA ### 1358307###Speaker###Professor###University of Kentucky, College of Pharmacy, Lexington, KY, USA###Speaker: Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA
### she/her/hers @@@ Frank Moriarty, MPharm PhD MPSI (he/him/his) – School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences ### 1658378###Speaker###Senior Lecturer###School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences###Speaker: Frank Moriarty, MPharm PhD MPSI (he/him/his) – School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences
### he/him/his @@@ Clare M. Johnson-Applin, PharmD, MS (she/her/hers) – University of Kentucky College of Pharmacy ### 2325385###Speaker###PhD Student###University of Kentucky College of Pharmacy###Speaker: Clare M. Johnson-Applin, PharmD, MS (she/her/hers) – University of Kentucky College of Pharmacy
### she/her/hers @@@ Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health ### 1302736###Speaker###Associate Professor###Brown University School of Public Health###Speaker: Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health
### he/him/hisPresenting Author: Svetla Slavova, PhD – University of Kentucky
### @@@ Sarah Hargrove, M.S. – University of Kentucky ### 2330970###Co-Author###Program Manager of KY Drug Overdose Fatality Surveillance System###University of Kentucky###Co-Author: Sarah Hargrove, M.S. – University of Kentucky
### @@@ Holly Hedegaard, MD, MSPH – Epidemiology Consulting, LLC ### 2330971###Co-Author###Medical Director###Epidemiology Consulting, LLC###Co-Author: Holly Hedegaard, MD, MSPH – Epidemiology Consulting, LLC
### @@@ Douglas Oyler, PharmD – University of Kentucky ### 2330972###Co-Author###Assistant Professor###University of Kentucky###Co-Author: Douglas Oyler, PharmD – University of Kentucky
### @@@ Bruce A. Goldberger, Ph.D. – University of Kentucky ### 2330973###Co-Author###Consultant###University of Kentucky###Co-Author: Bruce A. Goldberger, Ph.D. – University of Kentucky
### @@@ Peter Akpunonu, MD – University of Kentucky ### 2330974###Co-Author###Associate Professor###University of Kentucky###Co-Author: Peter Akpunonu, MD – University of Kentucky
### @@@ Krassimir Slavov, MS – University of Kentucky ### 2330975###Co-Author######University of Kentucky###Co-Author: Krassimir Slavov, MS – University of Kentucky
### @@@ Nabarum Dasgupta, PhD – University of North Carolina ### 2330976###Co-Author######University of North Carolina###Co-Author: Nabarum Dasgupta, PhD – University of North Carolina
### @@@ Dana Quesinberry, JD, DrPH – University of Kentucky, College of Public Health ### 2330977###Co-Author###Assistant Professor, Associate Director of Kentucky Injury Prevention and Research Center###University of Kentucky, College of Public Health###Co-Author: Dana Quesinberry, JD, DrPH – University of Kentucky, College of Public Health
### @@@ Lara Daniels, MPH – KIPRC, University of Kentucky ### 2330978###Co-Author###Epidemiologist###KIPRC, University of Kentucky###Co-Author: Lara Daniels, MPH – KIPRC, University of Kentucky
### @@@ William Ralston, MD – Kentucky State Medical Examiner's Office ### 2330979###Co-Author###Chief Medical Examiner###Kentucky State Medical Examiner's Office###Co-Author: William Ralston, MD – Kentucky State Medical Examiner's Office
### @@@ Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy ### 1656010###Co-Author###Professor###University of Kentucky College of Pharmacy###Co-Author: Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy
###Lead Speaker: Priscilla Velentgas, PhD (she/her/hers) – Merck
### she/her/hers @@@ Cynthia J. Girman, DrPH, FISPE (she/her/hers) – CERobs Consulting, LLC ### 2328663###Speaker###Founder & CEO###CERobs Consulting, LLC###Speaker: Cynthia J. Girman, DrPH, FISPE (she/her/hers) – CERobs Consulting, LLC
### she/her/hers @@@ Noelle M. Cocoros, DSc, MPH – Harvard Pilgrim Health Care Institute, Dept. of Population Medicine ### 2325327###Speaker###Principal Research Scientist###Harvard Pilgrim Health Care Institute, Dept. of Population Medicine###Speaker: Noelle M. Cocoros, DSc, MPH – Harvard Pilgrim Health Care Institute, Dept. of Population Medicine
### @@@ Sebastian Weis ### 2455588###Speaker#########Speaker: Sebastian Weis
###Lead Speaker: Andrea V. Margulis, MD, ScD, FISPE – RTI Health Solutions, Barcelona, Spain
### @@@ Brian T. Bateman, MD, MSc – Stanford University ### 1088175###Speaker######Stanford University###Speaker: Brian T. Bateman, MD, MSc – Stanford University
### @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Speaker###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###Speaker: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
### @@@ Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1359931###Speaker###Associate Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###Speaker: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1360167###Speaker###Deputy Director for Safety###Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###Speaker: Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
###Moderator: Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### he/him/his @@@ Carla Torre, PharmD, MSc, PhD – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal ### 1359276###Moderator###Assistant Professor###Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal###Moderator: Carla Torre, PharmD, MSc, PhD – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal
###Moderator: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ G. Niklas Norén, PhD – Uppsala Monitoring Centre ### 2329935###Moderator###Chief Science Officer###Uppsala Monitoring Centre###Moderator: G. Niklas Norén, PhD – Uppsala Monitoring Centre
###Presenting Author: Liang-Yi Lin, MS (she/her/hers) – Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
### she/her/hers @@@ Shih-Tsung Huang, PharmD, PhD – Department of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan ### 1093541###Co-Author###Project Assistant Professor###Department of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan###Co-Author: Shih-Tsung Huang, PharmD, PhD – Department of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan
### @@@ Liang-Kung Chen, MD,PhD – Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan ### 1358740###Co-Author######Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan###Co-Author: Liang-Kung Chen, MD,PhD – Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan
### @@@ Fei-Yuan Hsiao, PhD – Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan ### 1358452###Co-Author######Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan###Co-Author: Fei-Yuan Hsiao, PhD – Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
###